Search results for "Cardiology"

showing 10 items of 6064 documents

Tetrodotoxin slightly shortens action potential duration in ventricular but not in atrial heart muscle.

1988

Tetrodotoxin (TTX), at concentrations significantly decreasing maximal upstroke velocity (dV/dtmax) of the action potential, exerted variable effects on action potential duration (APD) in different myocardial preparations. APD was virtually unchanged by tetrodotoxin in the guinea pig atrium, but slightly shortened in the guinea pig ventricle at maximally effective concentrations. In the human ventricle, both dV/dtmax and APD were reduced in the same concentration range of TTX. These results suggest that a TTX-sensitive sodium current significantly contributes to the repolarization phase of the action potential in ventricular but not in atrial heart muscle.

medicine.medical_specialtyHeart VentriclesGuinea PigsAction PotentialsTetrodotoxinBiologySodium currentGuinea pigCellular and Molecular Neurosciencechemistry.chemical_compoundInternal medicinemedicineRepolarizationAnimalsHumansVentricular FunctionHeart AtriaAtrium (heart)Molecular BiologyPharmacologymusculoskeletal neural and ocular physiologySodiumHeartCell BiologyAtrial FunctionElectrophysiologymedicine.anatomical_structurechemistryVentriclecardiovascular systemTetrodotoxinCardiologyMolecular MedicineAction potential durationCalciumcirculatory and respiratory physiologyExperientia
researchProduct

Rheumatoid arthritis affects left ventricular mass: Systematic review and meta-analysis.

2015

Abstract Background Cardiovascular disease represents one of the most important extra-articular causes of morbidity and mortality in patients with rheumatoid arthritis (RA). Evidences showed that several cardiac structures can be affected during the course of the disease as well as abnormalities of left ventricular diastolic filling. Contrasting data are available about left ventricular mass (LVM) involvement in patients asymptomatic for cardiovascular disease. The purpose of this systematic review and meta-analysis is to summarize the effects of RA on LVM in rheumatoid arthritis patients without cardiovascular disease. Methods A systematic research of the current case–control studies was c…

medicine.medical_specialtyHeart VentriclesLeft ventricular maDiastoleAsymptomaticInterventricular septum thickneArthritis RheumatoidDiastoleInternal medicinemedicineInternal MedicineHumansClinical significanceRheumatoid arthritibusiness.industrymedicine.diseaseLeft ventricular posterior wall thickneClinical trialPooled varianceStrictly standardized mean differenceEchocardiographyRheumatoid arthritisMeta-analysisCardiologymedicine.symptombusinessEuropean journal of internal medicine
researchProduct

Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance

2012

Myocardial infarction is a major cause of death and disability worldwide. Myocardial infarction may represent a major catastrophic event leading to severe hemodynamic failure or sudden death or it may occur repeatedly in patients with established heart disease. In this context, the role of imaging techniques may become useful for the understanding of the determinants in a preclinical setting before acute coronary events, and for an accurate and correct diagnosis of myocardial infarction. Three-dimensional noninvasive imaging techniques, such as Cardiac CT (CCT) and Cardiac MR imaging (CMR) were widely developed in the last two decades. These imaging techniques may provide new insights into …

medicine.medical_specialtyHeart diseaseContext (language use)Coronary Artery DiseaseSudden deathInternal medicineMedicineHumanscardiovascular diseasesMyocardial infarctionPharmacologymedicine.diagnostic_testbusiness.industryCoronary StenosisElectrocardiography in myocardial infarctionMagnetic resonance imagingmedicine.diseaseCoronary arteriesMyocardial infarctionmedicine.anatomical_structurecardiovascular systemCardiologyRadiologyMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessMagnetic Resonance AngiographyTomography Emission-Computed
researchProduct

The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS

2008

Atrial fibrillation (AF) is the most common rhythm disturbance in medical practice and represents a very expensive health problem. AF can be managed with the prevention of thromboembolism and either a rate control of rhythm strategy. As both strategies have important limitations, probably a preventative strategy in patients at risk of developing arrhythmia can be a more attractive option. The renin-angiotensin system (RAS) seems to be involved in the genesis of arrhythmia by the following two mechanisms: 1. the induction of atrial fibrosis and structural remodelling by mitogen-activated protein kinase (MAPK) expression and reduction of collagenase activity; 2. the induction of electrical re…

medicine.medical_specialtyHeart diseaseGenotypeElectric CountershockAngiotensin-Converting Enzyme InhibitorsReview ArticleRenin-Angiotensin Systemrenin-angiotensin system atrial fibrillation ACE-I ARBDiabetes mellitusInternal medicineRenin–angiotensin systemAtrial FibrillationmedicineHumansPharmacology (medical)PharmacologyMitogen-Activated Protein Kinase KinasesEvidence-Based Medicinebiologybusiness.industryAngiotensin IIfungifood and beveragesAtrial fibrillationAngiotensin-converting enzymemedicine.diseaseAngiotensin IIEndocrinologyHeart failureACE inhibitorCardiologybiology.proteinbusinessAnti-Arrhythmia Agentsmedicine.drug
researchProduct

Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.

2021

With increasing life-expectancy and changing demographics, non-valvular atrial fibrillation (AF) is currently the most common indication for long-term oral anticoagulation (OAC) in low and middle income countries (LMICs). Due to a decreasing trend in the prevalence of rheumatic heart disease (RHD), valve disease as a primary cause of AF now constitutes a small fraction of all people with AF. Moreover, emerging data also indicate that, patients with significant valve disease and AF may have a risk of stroke similar to, if not lower than, those with non-valvular AF. Previous trials of anticoagulation for AF excluded people from LMICs partly because valvular AF constituted a large proportion o…

medicine.medical_specialtyHeart diseaseRD1-811medicine.drug_classMEDLINEAdministration Oral030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineThromboembolismAtrial FibrillationOpinion PapermedicineDiseases of the circulatory (Cardiovascular) systemHumans030212 general & internal medicineMedical prescriptionIntensive care medicineStrokeDeveloping Countriesbusiness.industryvalvular heart diseaseAnticoagulantsAtrial fibrillationVitamin K antagonistmedicine.diseaseClinical trialStrokeRC666-701SurgeryCardiology and Cardiovascular MedicinebusinessIndian heart journal
researchProduct

Obstructive sleep apnea and Alzheimer’s disease-related cerebrospinal fluid biomarkers in mild cognitive impairment

2020

Abstract Previous studies have demonstrated that sleep-breathing disorders, and especially obstructive sleep apnea (OSA), can be observed in patients with a higher risk of progression to Alzheimer’s disease (AD). Recent evidence indicates that cerebrospinal fluid (CSF) AD-biomarkers are associated with OSA. In this study, we investigated these associations in a sample of patients with mild cognitive impairment (MCI), a condition that is considered the first clinical phase of AD, when patients showed biomarkers consistent with AD pathology. A total of 57 patients (mean age = 66.19; SD = 7.13) with MCI were included in the study. An overnight polysomnography recording was used to assess objec…

medicine.medical_specialtyHeart diseaseRapid eye movement sleeptau ProteinsPolysomnography03 medical and health sciences0302 clinical medicineAlzheimer DiseasePhysiology (medical)Internal medicinemedicineHumansCognitive DysfunctionAgedSleep Apnea ObstructiveAmyloid beta-Peptidesmedicine.diagnostic_testbusiness.industryApneamedicine.diseaseSleep in non-human animalsPeptide FragmentsObstructive sleep apnea030228 respiratory systemCardiologyNeurology (clinical)medicine.symptombusinessHypopneaBody mass indexBiomarkers030217 neurology & neurosurgerySleep
researchProduct

Electrochemical nano-immunosensing of effective cardiac biomarkers for acute myocardial infarction

2013

Abstract This review provides an overview of the various types of electrochemical immunosensors that have been developed for determination of cardiac biomarkers, along with significant advances over the last several years in related technologies. We also summarize the latest developments in the applications of electrochemical immunosensors in ultrasensitive detection of electroactive cardiac biomarkers.

medicine.medical_specialtyHeart diseasebiologyCardiac biomarkersbusiness.industrymedicine.diseaseTroponinAnalytical Chemistrychemistry.chemical_compoundMyoglobinchemistryInternal medicinemedicineCardiologybiology.proteinMyocardial infarctionbusinessSpectroscopyTrAC Trends in Analytical Chemistry
researchProduct

Treatment and Prophylaxis

1991

Following a stroke, the patient’s neurologic deficit may be most impressive, but his treatment and prognosis depend largely upon accompanying systemic disorders. Acute treatment, for instance, must take into consideration such things as cardiovascular disorders (myocardial infarction, valve defects, arrhythmias, hypertension), disorders of renal function, and diabetes mellitus. The early detection and treatment of such systemic problems can help to prevent complications that would be difficult to control later. Thus, in a patient with latent heart disease hypervolemic therapy with low molecular weight dextran may in fact elicit right heart failure and pulmonary edema instead of helping the …

medicine.medical_specialtyHeart diseasebusiness.industryCerebral infarctionRenal functionmedicine.diseasePulmonary edemaLow molecular weight dextranRight heart failureDiabetes mellitusInternal medicinemedicineCardiologyMyocardial infarctionbusiness
researchProduct

Giant left atrium: a condition that is rarely seen today.

2008

Today, giant left atrium is a condition that is rarely observed in clinical practice and diagnosis can be missed. It is prevalent in patients with rheumatic heart disease that has decreased considerably in industrialized countries in the last two decades. However, the immigration flow in the current era can revive its incidence.

medicine.medical_specialtyHeart diseasebusiness.industryGeneral surgeryIncidence (epidemiology)fungiRheumatic Heart Diseasefood and beveragesCardiomegalyGeneral MedicineMiddle AgedGiant left atriummedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareClinical PracticeMedicineHumansIn patientFemaleHeart AtriaCardiology and Cardiovascular MedicinebusinessGiant left atriumJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Blood pressure variability and cardiovascular risk in 9 eastern european countries: data from the BP-Care study

2015

Methods: Total 327 patients were enrolled from 2008 to 2011 in the Korean registry program. They met the criteria of PAH and we investigated the clinical data, the medication prescribed and survival status et al. Results: Their mean age was 40.8 15.8years with female /male patient ratio of 2.7:1. The patients in WHO I/II were 32.4% and WHO III/IV were 67.6%. The peak/mean pulmonary arterial pressure was 86.3/ 56.6 mmHg. Idiopathic PAH (22%), connective tissue disease (24%) and congenital heart disease (46%) were predominant. Small number of patients with familial PAH, portal hypertension, HIV infection, pulmonary capillary hemangiomatosis (PCH) existed. The patients described bosentan were …

medicine.medical_specialtyHeart diseasebusiness.industrySildenafilPulmonary capillary hemangiomatosismedicine.diseaseBosentanEastern europeanchemistry.chemical_compoundBlood pressurechemistryInternal medicineInternal MedicinemedicineCardiology and Cardiovascular MedicinebusinessSurvival ratemedicine.drugCohort studyJournal of the American Society of Hypertension
researchProduct